ENDRA Life Sciences (NASDAQ:NDRA) Announces Quarterly Earnings Results, Misses Expectations By $5.30 EPS

ENDRA Life Sciences (NASDAQ:NDRA) announced its quarterly earnings results on Monday. The company reported ($9.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($4.10) by ($5.30), Zacks reports.

ENDRA Life Sciences Stock Performance

ENDRA Life Sciences stock opened at $4.05 on Tuesday. The company has a market capitalization of $2.17 million, a P/E ratio of 0.00 and a beta of 0.43. ENDRA Life Sciences has a fifty-two week low of $3.15 and a fifty-two week high of $875.00. The stock has a 50-day simple moving average of $4.59 and a 200-day simple moving average of $5.94.

About ENDRA Life Sciences

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.